In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates

Prostate

Volumn 41, Issue 2, 1999, Pages 99-109

  Chan, Peter S F ^a   Chan, L W ^a   Xuan, Jim W ^b   Chin, Joseph L ^b   Choi, H L ^a   Chan, Franky L ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Human prostate; In situ hybridization; PSP94; microseminoprotein; Tumor marker

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; BETA MICROSEMINOPROTEIN; MESSENGER RNA; PROSTATE PROTEIN; PROSTATE SPECIFIC ANTIGEN; SECRETORY PROTEIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FETUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NUCLEOTIDE SEQUENCE; PRECANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; DOWN-REGULATION; EMBRYONIC AND FETAL DEVELOPMENT; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PEPTIDES; PROSTATE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; PUBERTY; RNA, MESSENGER;

EID: 0032858242     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19991001)41:2<99::AID-PROS4>3.0.CO;2-C     Document Type: Article

References (55)

1. Lilja H, Abrahamsson P-A. Three predominant proteins secreted by the human prostate gland. Prostate 1988;12:29-38.
2. Hara M, Kimura H. Two prostate-specific antigens, γ-seminoprotein and β-microseminoprotein. J Lab Clin Med 1989;113: 541-548.
3. Seidah NG, Arbatti NJ, Rochemont J, Sheth AR, Chrétien M. Complete amino acid sequence of human seminal plasma β-inhibin. Prediction of post Gln-Arg cleavage as a maturation site. FEBS Lett 1984;175:349-355.
4. Doctor VM, Sheth AR, Simha MM, Arbatti NJ, Aaveri JP, Sheth NA. Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates. Br J Cancer 1986;53:547-554.
5. Akiyama K, Yoshioka Y, Schmid K, Offner GD, Troxler RF, Tsuda R, Hara M. The amino acid sequence of human β-microseminoprotein. Biochim Biophys Acta 1985;829:288-294.
6. Mbikay M, Nolet S, Fournier S, Benjannet S, Chapdelaine P, Paradis G, Dubé JY, Tremblay R, Larzure C, Seidah NG, Chrétien M. Molecular cloning and sequence of the cDNA for a 94-amino-acid seminal plasma protein secreted by the human prostate. DNA 1987;6:23-29.
7. Liang ZG, Kamada M, Koide SS. Structural identity of immunoglobulin binding factor and prostatic secretory protein of human seminal plasma. Biochem Biophys Res Commun 1991;180: 356-359.
8. Carter D, Resnick MI. High resolution analysis of human prostatic fluid by two-dimensional electrophoresis. Prostate 1982;3: 27-33.
9. Dubé JY, Frenette G, Faquin R, Chapdelaine P, Tremblay J, Tremblay RR, Lazure C, Seidah N, Chrétien M. Isolation from human seminal plasma of an abundant 16-kDa protein originating from the prostate, its identification with a 94-residue peptide originally described as β-inhibin. J Androl 1987;8:182-189.
10. Tremblay J, Frenette G, Tremblay RR, Dupont A, Thabet M, Dubé JY. Excretion of three major prostatic secretory proteins in the urine of normal and patients with benign prostatic hypertrophy or prostate cancer. Prostate 1987;10:235-243.
11. 94 or β-inhibin, and demonstration of transcripts in non-genital tissues. Biochem Biophys Res Commun 1989;164:1310-1315.
12. Green CB, Liu WY, Kwok SCM. Cloning and nucleotide sequence analysis of the human β-microseminoprotein gene. Biochem Biophys Res Commun 1990;167:1184-1190.
13. 94 suggested by sequence divergence between rhesus monkey and human cDNAs. Genomics 1991;9: 775-777.
14. Ulvsbäck M, Spurr NK, Lundwall Å. Assignment of the human gene for β-microseminoprotein (MSMB) to chromosome 10 and demonstration of related genes in other vertebrates. Genomics 1991;11:920-924.
15. Ochiai Y, Inazawa J, Ueyama H, Ohkubo I. Human gene for β-microseminoprotein: its promoter structure and chromosomal localization. J Biochem (Tokyo) 1995;117:346-352.
16. Xuan JW, Chin JL, Guo YZ, Chambers AF, Finkelman MA, Clarke MW. Alternative splicing of PSP94 (prostatic secretory protein of 94 amino acids) mRNA in prostate tissue. Oncogene 1995;11:1041-1047.
17. Johansson J, Sheth A, Cederlund E, Jörnvall H. Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Lett 1984;176:21-26.
18. Kamada M, Mori H, Maeda N, Yamamoto S, Kunimi K, Takikawa M, Maegawa M, Aono T, Futaki S, Koide SS. β-microseminoprotein/prostatic secretory protein is a member of immunoglobulin binding factor family. Biochim Biophys Acta 1998; 1388:101-110.
19. Huang CL, Liang HM, Brassil D, Schellhammer PF, Rozzell M, Newhall K, Beckett ML, Wright GL Jr. Two-site monoclonal antibody-based immunoradiometric assay for measuring prostate secretory protein in serum. Clin Chem 1992;38:817-823.
20. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, Saito Y. Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 1993;22:347-355.
21. Garde SV, Sheth AR, Porter AT, Pienta KJ. A comparative study on expression of prostatic inhibin peptide, prostate acid phosphatase and prostate specific antigen in androgen independent human and rat prostate carcinoma cell lines. Cancer Lett 1993; 70:159-166.
22. Garde S, Sheth A, Porter AT, Pienta KJ. Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 1993;22:225-133.
23. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor. Cancer Res 1993;53:4855-4859.
24. Kohan S, Fröysa B, Cederlund E, Fairwell T, Lerner R, Johansson J, Khan S, Ritzen M, Cekan S, Diczfalusy E. Peptides of postulated inhibin activity. Lack of in vitro inhibin activity of a 94-residue peptide isolated from human seminal plasma, and of a synthetic replicate of its C-terminal 28-residue segment. FEBS Lett 1986;199:242-248.
25. Gordon WL, Liu WK, Akiyama K, Tsuda R, Hara M, Schmid K, Ward DN. Beta-microseminoprotein (β-MSP) is not an inhibin. Biol Reprod 1987;36:829-835.
26. Wright GL Jr, Huang CL, Lipford G, Beckett ML, Liang HM, Haley C, Newhall K, Morningstar M. Generation and characterization of monoclonal antibodies to prostate secretory protein. Int J Cancer 1990;46:39-49.
27. Ito Y, Tsuda R, Kimura H. Ultrastructural localization of β-microseminoprotein, a prostate-specific antigen, in human prostate and sperm: comparison with γ-seminoprotein, another prostate-specific antigen. J Lab Clin Med 1989;114:272-277.
28. +-ATPase. Biochem Biophys Res Commun 1996;218:623-628.
29. 94: gene organization and promoter sequence in rhesus monkey and human. Biochim Biophys Acta 1991;1089:247-249.
30. Xuan JW, Wu DM, Guo YZ, Garde S, Shum DT, Mbikay M, Zhong R, Chin JL. Molecular cloning and gene expression analysis of PSP94 (prostate secretory protein of 94 amino acids) in primates. DNA Cell Biol 1997;16:627-638.
31. Fernlund P, Granberg L, Roepstorff P. Amino acid sequence of β-microseminoprotein from porcine seminal plasma. Arch Biochem Biophys 1994;309:70-76.
32. 94-like protein. Mol Reprod Dev 1995;42:149-156.
33. Fernlund P, Granberg L, Larsson I. Cloning of β-microseminoprotein of the rat: a rapidly evolving mucosal surface protein. Arch Biochem Biophys 1996;334:73-82.
34. Xuan JW, Kwong J, Chan FL, Ricci M, Imasato Y, Sakai H, Fong GH, Panchal C, Chin JL. cDNA, genomic cloning, and gene expression analysis of mouse PSP94 (prostate secretory protein of 94 amino acids). DNA Cell Biol 1999;18:11-26.
35. Weiber H, Andersson C, Murne A, Rannevik G, Lindström C, Lilja H, Fernlund P. β microseminoprotein is not a prostate-specific protein. Its identification in mucous glands and secretions. Am J Pathol 1990;137:593-604.
36. Weiber H, Lindström C, Lilja H, Bjartell A, Fernlund P. Immunohistochemical and in situ hybridization studies of β-microseminoprotein in the human gastric mucosa. Histochem J 1997;29: 839-845.
37. Ohkubo I, Tada T, Ochial Y, Ueyama H, Eimoto T, Sasaki M. Human seminal plasma β-microseminoprotein: its purification, characterization, and immunohistochemical localization. Int J Biochem Cell Biol 1995;27:603-611.
38. 35S- and digoxigenin-labeled RNA and oligonucleotide probes for in situ hybridization. Histochemistry 1992;98:217-228.
39. Chan FL, Choi HL. Proteoglycans associated with the ciliary zonule of the rat eye: a histochemical and immunocytochemical study. Histochem Cell Biol 1995;104:369-381.
40. Andrews GS. The histology of the human foetal and prepubertal prostates. J Anat 1951;85:44-54.
41. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968;49:347-357.
42. McNeal JE. Anatomy of the prostate: an historical survey of divergent views. Prostate 1980;1:3-13.
43. Rui H, Mevag B, Purvis K. Two-dimensional electrophoresis of proteins in various fractions of the human split ejaculate. Int J Androl 1984;7:509-520.
44. Dubé JY, Pelletier G, Gagnon P, Tremblay RR. Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases. J Urol 1987;138:883-887.
45. Brar A, Mbikay M, Sirois F, Fournier S, Seidah NG, Chrétien M. Localization of the human prostatic secretory protein PSP94 and its mRNA in the epithelial cells of the prostate. J Androl 1988; 9:253-260.
46. Tsurusaki T, Koji T, Sakai H, Kanetake H, Nakane PK, Saito Y. Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer. Prostate 1998;35:109-116.
47. Kellokumpu-Lehtinen P, Santti R, Pelliniemi LJ. Development of human fetal prostate in culture. Urol Res 1981;9:89-98.
48. Kellokumpu-Lehtinen P. Localization of acid phosphatase activity in testosterone-treated prostatic urethra of human fetuses. Prostate 1983;4:265-270.
49. Zondek T, Mansfield MD, Attree SL, Zondek LH. Hormone levels in the foetal and neonatal prostate. Acta Endocrinol (Copenh) 1986;112:447-456.
50. Aumüller G, Groos S, Renneberg H, Konrad L, Aumüller M. Embryology and postnatal development of the prostate. In: Foster CS, Bostwick DG, editors. Pathology of the prostate. Major problems in pathology, volume 34. Philadelphia: W.B. Saunders; 1998. p 1-18.
51. Lowley OS. The development of the human prostate gland with reference to the development of other structures at the neck of the urinary bladder. Am J Anat 1912;13:299-349.
52. Sathe VS, Sheth NA, Phadke MA, Sheth AR, Zaveri JP. Biosynthesis and localization of inhibin in human prostate. Prostate 1987;10:33-43.
53. Sheth NA, Doctor VM, Sampat MB, Garde SV, Arbatt NJ, Sheth AR. Inhibin-like material - an immunohistologic marker for prostatic origin of metastases. Cancer Lett 1987;36:93-98.
54. Sathe VS, Sheth AR, Sheth NA. Distribution of immunoreactive inhibin like material in different regions of human prostate. Andrologia 1987;19:18-21.
55. Abrahamsson P-A, Lilja H, Falkmer S, Wadström LB. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate 1988;12:39-46.